Concepedia

Post-Treatment Bone Marrow Residual Disease > 5% by Flow Cytometry Is Highly Predictive of Short Progression-Free and Overall Survival in Patients With Waldenström's Macroglobulinemia

Ramón García‐Sánz, Roberto JP Magalhaes, Jennifer Alonso, Lucía López‐Anglada, Teresa Villaescusa, Noemí Puig, Javier Fernández‐Calvo, Armando Aguilar, Bruno Paiva, Jesús F. San Miguel,

Clinical Lymphoma Myeloma & Leukemia · 2011 · 19 citations · 10 references

DOI

Concepts

References

10

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

Bruno Paiva, María‐Belén Vídriales, Jorge Cerveró et al. · Blood · 2008 · 475 citations · Full text

, , +17

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

Andy C. Rawstron, Neus Villamor, Matthias Ritgen et al. · Leukemia · 2007 · 399 citations

, , +13

How I treat Waldenström macroglobulinemia

Steven P. Treon · Blood · 2015 · 287 citations · Full text

, , +2

Initial immunoglobulin M ‘flare’ after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia

Irene M. Ghobrial, Rafaël Fonseca, Philip R. Greipp et al. · Cancer · 2004 · 207 citations · Full text

, , +11

Immunophenotypic analysis of Waldenstrom's macroglobulinemia

Jesús F. San Miguel, María‐Belén Vídriales, Enrique M. Ocio et al. · Seminars in Oncology · 2003 · 180 citations

, , +6